These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34481190)

  • 1. Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation.
    Schoger E; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2021 Oct; 56():102518. PubMed ID: 34481190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
    Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
    Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
    Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression.
    Schoger E; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2021 Aug; 55():102473. PubMed ID: 34343828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
    Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C
    F1000Res; 2019; 8():1911. PubMed ID: 32789000
    [No Abstract]   [Full Text] [Related]  

  • 6. Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons.
    Wu Q; Wu J; Karim K; Chen X; Wang T; Iwama S; Carobbio S; Keen P; Vidal-Puig A; Kotter MR; Bassett A
    Mol Cell; 2023 Apr; 83(7):1125-1139.e8. PubMed ID: 36917981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining a tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC).
    Priesmeier L; Schoger E; Cyganek L; Cecilia Zelarayán L
    Stem Cell Res; 2023 Sep; 71():103163. PubMed ID: 37433260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
    Gu J; Rollo B; Sumer H; Cromer B
    Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
    Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
    Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the "safe harbor" AAVS1 locus.
    Castaño J; Bueno C; Jiménez-Delgado S; Roca-Ho H; Fraga MF; Fernandez AF; Nakanishi M; Torres-Ruiz R; Rodríguez-Perales S; Menéndez P
    Stem Cell Res; 2017 May; 21():137-140. PubMed ID: 28677529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation.
    Omachi K; Miner JH
    PLoS One; 2022; 17(6):e0270008. PubMed ID: 35763517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila.
    Lin S; Ewen-Campen B; Ni X; Housden BE; Perrimon N
    Genetics; 2015 Oct; 201(2):433-42. PubMed ID: 26245833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using an Inducible CRISPR-dCas9-KRAB Effector System to Dissect Transcriptional Regulation in Human Embryonic Stem Cells.
    Parsi KM; Hennessy E; Kearns N; Maehr R
    Methods Mol Biol; 2017; 1507():221-233. PubMed ID: 27832543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient Cas9-mediated transcriptional programming.
    Chavez A; Scheiman J; Vora S; Pruitt BW; Tuttle M; P R Iyer E; Lin S; Kiani S; Guzman CD; Wiegand DJ; Ter-Ovanesyan D; Braff JL; Davidsohn N; Housden BE; Perrimon N; Weiss R; Aach J; Collins JJ; Church GM
    Nat Methods; 2015 Apr; 12(4):326-8. PubMed ID: 25730490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.
    Oceguera-Yanez F; Kim SI; Matsumoto T; Tan GW; Xiang L; Hatani T; Kondo T; Ikeya M; Yoshida Y; Inoue H; Woltjen K
    Methods; 2016 May; 101():43-55. PubMed ID: 26707206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.